Anti-PPFIA1 monoclonal antibody

Pre-made anti-PPFIA1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PPFIA1/PPFIA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1434-Ab-1/ GM-Tg-hg-IP1434-Ab-2Anti-Human PPFIA1 monoclonal antibodyHuman
GM-Tg-rg-IP1434-Ab-1/ GM-Tg-rg-IP1434-Ab-2Anti-Rat PPFIA1 monoclonal antibodyRat
GM-Tg-mg-IP1434-Ab-1/ GM-Tg-mg-IP1434-Ab-2Anti-Mouse PPFIA1 monoclonal antibodyMouse
GM-Tg-cynog-IP1434-Ab-1/ GM-Tg-cynog-IP1434-Ab-2Anti-Cynomolgus/ Rhesus macaque PPFIA1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1434-Ab-1/ GM-Tg-felg-IP1434-Ab-2Anti-Feline PPFIA1 monoclonal antibodyFeline
GM-Tg-cang-IP1434-Ab-1/ GM-Tg-cang-IP1434-Ab-2Anti-Canine PPFIA1 monoclonal antibodyCanine
GM-Tg-bovg-IP1434-Ab-1/ GM-Tg-bovg-IP1434-Ab-2Anti-Bovine PPFIA1 monoclonal antibodyBovine
GM-Tg-equg-IP1434-Ab-1/ GM-Tg-equg-IP1434-Ab-2Anti-Equine PPFIA1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1434-Ab-1/ GM-Tg-hg-IP1434-Ab-2; GM-Tg-rg-IP1434-Ab-1/ GM-Tg-rg-IP1434-Ab-2;
GM-Tg-mg-IP1434-Ab-1/ GM-Tg-mg-IP1434-Ab-2; GM-Tg-cynog-IP1434-Ab-1/ GM-Tg-cynog-IP1434-Ab-2;
GM-Tg-felg-IP1434-Ab-1/ GM-Tg-felg-IP1434-Ab-2; GM-Tg-cang-IP1434-Ab-1/ GM-Tg-cang-IP1434-Ab-2;
GM-Tg-bovg-IP1434-Ab-1/ GM-Tg-bovg-IP1434-Ab-2; GM-Tg-equg-IP1434-Ab-1/ GM-Tg-equg-IP1434-Ab-2
Products NameAnti-PPFIA1 monoclonal antibody
Formatmab
Target NamePPFIA1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PPFIA1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1434-Ag-1Recombinant multi-species LIPA1/ PPFIA1/ LIP.1 protein


    Target information

    Target IDGM-IP1434
    Target NamePPFIA1
    Gene ID8500,233977,293645,708387,475999,101088110,100139635,100147331
    Gene Symbol and SynonymsC030014K08Rik,LIP.1,LIP1,LIPRIN,PPFIA1
    Uniprot AccessionQ13136
    Uniprot Entry NameLIPA1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000131626
    Target ClassificationN/A

    The target: PPFIA1, gene name: PPFIA1, also named as LIP.1, LIP1, LIPRIN. The protein encoded by this gene is a member of the LAR protein-tyrosine phosphatase-interacting protein (liprin) family. Liprins interact with members of LAR family of transmembrane protein tyrosine phosphatases, which are known to be important for axon guidance and mammary gland development. This protein binds to the intracellular membrane-distal phosphatase domain of tyrosine phosphatase LAR, and appears to localize LAR to cell focal adhesions. This interaction may regulate the disassembly of focal adhesion and thus help orchestrate cell-matrix interactions. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.